South Korea's ruling party held final negotiations with the opposition party on the budget.The case of 2024 New Quality Productivity Empowering High Quality Development was released. On December 10th, 2024 China Brand Forum New Quality Productivity Empowering High Quality Development Forum was held in Zhengzhou. At the meeting, the case of high-quality development of new quality productivity in 2024 was released, and 20 enterprises including China Railway Equipment, BYD, Yutong Group, Chihiro Location and Ubisoft Technology were selected. (Dahe Finance Cube)Gaode Infrared sued six former employees and their new owners for infringing on business secrets. The other company: Gaode Infrared announced that there were "false records and false statements". On the evening of December 5, Gaode Infrared announced that the company filed a civil lawsuit against Zhejiang Juexin Microelectronics Co., Ltd. (hereinafter referred to as Juexin Company), Mao Jianhong and six former employees for infringing on the company's business secrets, asking the defendant to pay 200 million yuan in economic losses and other things. On December 6th and 9th, Juexin Company issued statements on the announcement of Gaode Infrared on WeChat WeChat official account "Juexin Microelectronics", claiming that there were "false records, false statements, misleading statements or major omissions" in the above announcement of Gaode Infrared. (per warp net)
Morgan Stanley published a research report that Jingdong Logistics management predicted that the net profit growth in FY 2024 would increase by 49% year-on-year, far exceeding the bank's expected 30% increase. As for the profit growth forecast for next year, it is 9% year-on-year. The bank also believes that the acquisition of Jingdong Logistics across the remaining rights and interests of Express is positive and is expected to have further synergy. Morgan Stanley set the target price of H shares of Jingdong Logistics at HK$ 13.1, giving it a rating of "keeping pace with the market".Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Broad-based index products are expected to increase the Y share of personal pension, and personal pension products are expected to expand after the second anniversary of the personal pension system. It is understood that mainstream broad-based index products are expected to increase the personal pension Y share, including Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI A500 Index, GEM Index and other products, which can provide investors with more allocation needs. (SSE)
Australia's S&P/ASX 200 index closed at 8399.40 points, down 0.28%.Australia's 3-year bond yields fell by 3 basis points after the RBA commented on inflation.Sudan and South Sudan extended the opening hours of the humanitarian corridor between the two countries, and the governments of Sudan and South Sudan signed an agreement on December 9 local time to extend the opening hours of the humanitarian corridor between the two countries until February 2 next year. According to the agreement, air routes from South Sudan to Kadugli, the capital of South Kordofan State in Sudan, and Garad and Kaunau will continue to be open to facilitate the delivery of humanitarian aid from South Sudan to Sudan. After the agreement expires on February 2 next year, the two sides will also discuss the extension.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide